DOI : 10.1055/s-00000036

Laryngo-Rhino-Otologie

Issue S 02 · Volume 100 · May 2021 DOI: 10.1055/s-011-50823


100 JAHRE DGHNO-KHC: WO KOMMEN WIR HER? WO STEHEN WIR? WO GEHEN WIR HIN?
HNO-Online-Kongress, 12.05 - 16.05.2021

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn

Präsident: Prof. Dr. med. Stefan K. Plontke, Halle (Saale)

Busch, C-J; von der Heyde, E; Hahn, D; Langer, C; Müller-Huesmann, H; Kubuschok, B; Beutner, D; Klautke, G; Mauz, P-S; von der Grün, J; Büntzel, J; Riera-Knorrenschild, J; Tamaskovics, B; Welslau, M; Gauler, T; Waldenberger, D; Dietz, A: HANNA: Real-world outcomes of patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) treated with nivolumab (NIVO) in Germany
Bußmann, L; Hoffer, K; Betz, C; Busch, C-J; Münscher, A; Hapke, G; Kriegs, M: Kinase activity profiles as prognostic marker for immunotherapy in head and neck squamous cell carcinoma (HNSCC)
Lammert, A; Affolter, A; Heid, J; Jakob, Y; Jungbauer, F; Ludwig, S; Rotter, N; Scherl, C; Tenschert, E; Kern, J: Tyrosine kinase inhibitors in head and neck squamous cell carcinoma – a therapeutic chance?
Linxweiler, M; Makarov, V; Kuo, F; Katabi, N; Chowell, D; Wong, RJ.; Chan, TA.; Morris, Luc G. T.: Immunological Signature and Neoantigene Landscape of aggressive Salivary Gland Cancers
Seelig, C; Gehrke, T; Hackenberg, S; Hagen, R; Scherzad, A: Toxicity of salinomycin in combination with cisplatin in MDR-1-positive HNSCC cell lines
Vogt, T; Franzen, A; Bockhorst, C; Gabrielpillai, J; Strieth, S; Dietrich, D: The Potential of DNA Methylation of Immune Checkpoint Genes as Predictive Biomarker for Immunotherapies